OneSource Specialty Pharma Limited (NSE:ONESOURCE)

India flag India · Delayed Price · Currency is INR
1,346.80
+24.10 (1.82%)
At close: Feb 27, 2026
-0.14%
Market Cap 154.37B
Revenue (ttm) 14.19B
Net Income (ttm) 201.02M
Shares Out 114.62M
EPS (ttm) 1.75
PE Ratio 767.94
Forward PE 48.28
Dividend n/a
Ex-Dividend Date n/a
Volume 218,471
Average Volume 330,973
Open 1,332.00
Previous Close 1,322.70
Day's Range 1,299.70 - 1,350.00
52-Week Range 1,057.00 - 2,248.00
Beta n/a
RSI 52.11
Earnings Date May 7, 2026

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 1,412
Stock Exchange National Stock Exchange of India
Ticker Symbol ONESOURCE
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:ONESOURCE's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2024.

Financial Statements

News

There is no news available yet.